Genethon’s mission is to design gene therapy products for rare diseases, and to ensure their pre-clinical and clinical development in order to provide patients with access to these innovative treatments. To meet this challenge, Genethon has acquired the technical and human resources needed to accelerate the medical application of scientific discoveries arising from fundamental research. The translational research programs are supported by a first-rate technological platform and nearly 200 people (researchers, Pharm.Ds, M.Ds, Ph.Ds, engineers and technicians,…) who have joined forces in order to develop these innovative treatments.
Genethon’s DNA and Cell Bank is to promote advances in genetic research by providing the scientific community with a high quality cell and human tissue products resource.
Europe’s leading bank for genetic diseases, it serves the whole of the medical and scientific community.
Genethon has an imaging platform capable of generating and collecting all the clinical data which allow the evaluation of the efficiency, the toxicity and the side effects of the gene therapy product.
Genethon has platforms available which are capable of generating and collecting all the preclinical data which make it possible to evaluate efficacy, toxicity and adverse effects of a gene therapy product, including functional exploration, imaging, histology, cytology as well as an animal experimentation center
Visit website
